Because CD4IL2RALO cells significantly block cytotoxic CD4+ T cells from killing tumor cells,[18] the strong inhibition of CD4IL2RALO Tregs by Mito‐ATO could contribute to the observed increased proportion of activated cytotoxic CD 4+ T cells in TIME (Figures 10D and 11C). The gene discussed is CD4; the disease is neoplasm.